“Central” and “peripheral” benzodiazepine receptors: Opposite changes in human epileptogenic tissue

Neurology

Volumn 42, Issue 4, 1992, Pages 811-815

  Johnson, E W ^a   de Lanerolle, N C ^a   Kim, J H ^a   Sundaresan, S ^a   Spencer, D D ^a   Mattson, R H ^a   Zoghbi, S S ^a   Baldwin, R M ^a   Hoffer, P B ^a   Seibyl, J P ^a   Innis, Robert B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE; FLUMAZENIL; IOMAZENIL; RECEPTORS, GABA A; 4 AMINOBUTYRIC ACID RECEPTOR; BENZODIAZEPINE RECEPTOR; BENZODIAZEPINE; IODINE 125; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; RECEPTOR SUBTYPE; TRITIUM;

ADULT; ARTICLE; AUTORADIOGRAPHY; FEMALE; HIPPOCAMPUS; HUMAN; MALE; METABOLISM; PATHOLOGY; SCINTISCANNING; SCLEROSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE EPILEPSY; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPTIC FOCUS; GLIA; GLUCOSE METABOLISM; IMAGING; NEUROSURGERY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BINDING; DIAGNOSTIC ACCURACY; EPILEPTIC NERVE CELL; HUMAN TISSUE;

ADULT; AUTORADIOGRAPHY; EPILEPSY, TEMPORAL LOBE; FEMALE; FLUMAZENIL; HIPPOCAMPUS; HUMAN; MALE; RECEPTORS, GABA-A; SCLEROSIS; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0026609570     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.42.4.811     Document Type: Article

References (24)

1. Spencer SS, Spencer DD, Williamson PD, Mattson RH. The localizing value of depth electroencephalography in 32 patients with refractory epilepsy. Ann Neurol 1982;12:248- 253.
2. Spencer DD, Spencer SS. Surgery for epilepsy. In: Krantzler L, ed. Advances in neurosurgery, vol 3. Philadelphia: WB Saunders, 1985:313-330.
3. Spencer DD. Postscript: should there be a surgical treatment of choice, and if so, how should it be determined? In: Engel J, ed. Surgical treatment of the epilepsies. New York: Raven Press, 1987:477-484.
4. Sherwin A, Matthew E, Blain M, Guevremont D. Benzodiazepine receptor binding is not altered in human epileptogenic cortical foci. Neurology 1986;36:1380-1382.
5. Burnham WM, Hwang PA, Hoffman HJ, Becker LE, Murphy EG, Kish SJ. Benzodiazepine binding in human epileptic cortical tissue. In: Engel J, ed. Fundamental mechanisms of human brain function. New York: Raven Press, 1987:227-235.
6. Marangos PJ, Patel J, Boulenger J, Clark-Rosenberg R. Characterization of the peripheral-type benzodiazepine binding site in brain using [3H]Ro5-4864. Mol Pharmacol 1982;22:26-32.
7. Starosta-Rubinstein S, Ciliax BJ, Penney JB, McKeever P, Young AB. Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci USA 1987;84:891-895.
8. Dubois A, Benavides J, Peny B, et al. Imaging of primary and remote ischemic and excitotoxic brain lesions: an autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res 1988;445:77-90.
9. Black KL, Ikezaki K, Toga AW. Imaging of brain tumors using peripheral benzodiazepine receptor ligands. J Neurosurg 1989;71:113-118.
10. Johnson EW, Woods SW, Zoghbi S, McBride BJ, Baldwin RM, Innis RB. Receptor binding characterization of the benzodiazepine radioligand 125I-Rol6-0154: potential probe for SPECT brain imaging. Life Sci 1990;47:1535-1546.
11. Beer HF, Blauenstein P, Hasler P, et al. In vitro and in vivo evaluation of iodine-123-Rol6-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors. J Nucl Med 1990;31:1007-1014.
12. Innis RB, Al-Tikriti MS, Zoghbi S, et al. SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med 1991;32:1754-1761.
13. McBride BJ, Baldwin RM, Kerr JM, Wu JL. A simple method for the preparation of 1-123 and 1-125 labeled iodobenzodiazepines. Appl Radiat Isot 1991;42:173-175.
14. Kim JH, Guimaraes PO, Shen MY, Masukawa LM, Spencer DD. Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas. Acta Neuropathol (Berl) 1990;80:41-45.
15. Holman BL, Carvalho PA, Zimmerman RE, et al. Brain perfusion SPECT using an annular single crystal camera: initial clinical experience. J Nucl Med 1990;31:1456-1461.
16. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res 1989;495:387-395.
17. Dichter MA, Ayala GF. Cellular mechanisms of epilepsy: a status report. Science 1987;237:157-164.
18. Brailowsky S, Kunimoto M, Menini C, et al. The GABA- withdrawal syndrome: a new model for focal epileptogenesis. Brain Res 1988;442:175-179.
19. Olsen RW, Houser CR, Delgado-Escueta AV, Richards JG, Mohler H. Altered GABA-A/benzodiazepine receptor distribution in human temporal lobe epilepsy [abstract], Soc Neurosci Abstr 1990;16(part 1):448.
20. McDonald JW, Garofalo EA, Hood T, et al. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy. Ann Neurol 1991;29:529-541.
21. Savic I, Roland P, Sedvall G, Persson A, Pauli S, Widen C. In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 1988;2:863-866.
22. Mazziotta JC, Phelps ME. Positron emission tomography studies of the brain. In: Phelps ME, Mazziotta JC, Corsellis J, eds. Positron emission tomography and autoradiography: principles and applications for the brain and heart. New York: Raven Press, 1986:493-579.
23. Wilkinson IMS, Bull JWD, DuBoulay GH, Marshall J, Russel RW, Symon L. Regional blood flow in the normal cerebral hemisphere. J Neurol Neurosurg Psychiatry 1969;32:367-378.
24. Sokoloff L, Reivich M, Kennedy C, et al. The [14C] deoxyglu- cose method for the measurement of local cerebral glucose utilization: theory, procedure and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.